Skip to main content

MoneyWorks4Me

Anthem Biosciences - Quaterly Results

04 Nov 2026 Evaluate
The company's total revenue for the quarter ended September 2026 saw a slight change in the total revenue, having registered a total revenue of Rs. 5721.08 millions.A humble growth in net profit of 11.31% reported in the quarter ended September 2026 to Rs. 2208.86  millions from Rs. 1984.34 millions.OP of the company witnessed a marginal growth to 3293.94 millions from 2794.78 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202603 202503 % Var
Sales 5721.08 5527.03 3.51 9559.50 10907.14 -12.36 20893.12 18406.49 13.51
Other Income 646.95 533.22 21.33 932.95 810.50 15.11 1820.75 1094.40 66.37
PBIDT 3293.94 2794.78 17.86 4888.27 5026.35 -2.75 10331.96 7984.49 29.40
Interest 30.63 22.56 35.77 38.26 38.62 -0.93 65.47 90.89 -27.97
PBDT 3263.31 2772.22 17.71 4850.01 4987.73 -2.76 10026.36 7893.60 27.02
Depreciation 222.14 239.20 -7.13 445.24 465.32 -4.32 995.65 779.37 27.75
PBT 3041.17 2533.02 20.06 4404.77 4522.41 -2.60 9030.71 7114.23 26.94
TAX 832.31 548.68 51.69 1175.81 1054.66 11.49 2325.06 2052.36 13.29
Deferred Tax -19.76 -88.83 -77.76 -23.31 -83.54 -72.10 -87.99 232.08 -137.91
PAT 2208.86 1984.34 11.31 3228.96 3467.75 -6.89 6705.65 5061.87 32.47
Equity 1127.06 1123.22 0.34 1127.06 1123.22 0.34 1123.43 1118.15 0.47
PBIDTM(%) 57.58 50.57 13.86 51.14 46.08 10.96 49.45 43.38 14.00
Peers
Company Name CMP
Sun Pharma. Inds. 1880.90
Dr. Reddys Labs. 1377.00
Cipla 1393.00
Lupin 1980.00
Zydus Lifesciences 1191.00
View more..